145 related articles for article (PubMed ID: 29531381)
1. [Latest news and perspectives in cardiogenetics].
Malagù M; Zaraket F; Gualandi F; Ferlini A; Brieda A; Vitali F; Del Franco A; Balla C; Fucili A; Ferrari R; Bertini M
G Ital Cardiol (Rome); 2018 Feb; 19(2):91-100. PubMed ID: 29531381
[TBL] [Abstract][Full Text] [Related]
2. Personalized medicine: genetic diagnosis for inherited cardiomyopathies/channelopathies.
Ackerman MJ; Marcou CA; Tester DJ
Rev Esp Cardiol (Engl Ed); 2013 Apr; 66(4):298-307. PubMed ID: 24775620
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.
Tester DJ; Ackerman MJ
Circulation; 2011 Mar; 123(9):1021-37. PubMed ID: 21382904
[No Abstract] [Full Text] [Related]
4. Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association.
Ahmad F; McNally EM; Ackerman MJ; Baty LC; Day SM; Kullo IJ; Madueme PC; Maron MS; Martinez MW; Salberg L; Taylor MR; Wilcox JE
Circ Genom Precis Med; 2019 Jun; 12(6):e000054. PubMed ID: 31117808
[TBL] [Abstract][Full Text] [Related]
5. The role of genetics in primary ventricular fibrillation, inherited channelopathies and cardiomyopathies.
Crotti L; Kotta MC
Int J Cardiol; 2017 Jun; 237():45-48. PubMed ID: 28532586
[TBL] [Abstract][Full Text] [Related]
6. From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies.
Crotti L; Brugada P; Calkins H; Chevalier P; Conte G; Finocchiaro G; Postema PG; Probst V; Schwartz PJ; Behr ER
Europace; 2023 Aug; 25(8):. PubMed ID: 37622577
[TBL] [Abstract][Full Text] [Related]
7. [China expert consensus statement on genetic testing for cardiac channelopathies and cardiomyopathies].
;
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Dec; 39(12):1073-82. PubMed ID: 22336498
[No Abstract] [Full Text] [Related]
8. Genetics and sudden death.
Lombardi R
Curr Opin Cardiol; 2013 May; 28(3):272-81. PubMed ID: 23549233
[TBL] [Abstract][Full Text] [Related]
9. Interpretation of Incidental Genetic Findings Localizing to Genes Associated With Cardiac Channelopathies and Cardiomyopathies.
Ezekian JE; Rehder C; Kishnani PS; Landstrom AP
Circ Genom Precis Med; 2021 Aug; 14(4):e003200. PubMed ID: 34384235
[TBL] [Abstract][Full Text] [Related]
10. Channelopathies, genetic testing and risk stratification.
Wilde AAM; Amin A
Int J Cardiol; 2017 Jun; 237():53-55. PubMed ID: 28343764
[TBL] [Abstract][Full Text] [Related]
11. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
Ackerman MJ; Priori SG; Willems S; Berul C; Brugada R; Calkins H; Camm AJ; Ellinor PT; Gollob M; Hamilton R; Hershberger RE; Judge DP; Le Marec H; McKenna WJ; Schulze-Bahr E; Semsarian C; Towbin JA; Watkins H; Wilde A; Wolpert C; Zipes DP; ;
Europace; 2011 Aug; 13(8):1077-109. PubMed ID: 21810866
[No Abstract] [Full Text] [Related]
12. Evaluating the survivor or the relatives of those who do not survive: the role of genetic testing.
Tester DJ; Ackerman MJ
Cardiol Young; 2017 Jan; 27(S1):S19-S24. PubMed ID: 28084956
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnostics of cardiovascular diseases in sudden unexplained death.
Tang Y; Stahl-Herz J; Sampson BA
Cardiovasc Pathol; 2014; 23(1):1-4. PubMed ID: 24157219
[TBL] [Abstract][Full Text] [Related]
14. Inherited ion channel diseases: a brief review.
Lieve KV; Wilde AA
Europace; 2015 Oct; 17 Suppl 2():ii1-6. PubMed ID: 26842110
[TBL] [Abstract][Full Text] [Related]
15. Life threatening causes of syncope: channelopathies and cardiomyopathies.
Herman A; Bennett MT; Chakrabarti S; Krahn AD
Auton Neurosci; 2014 Sep; 184():53-9. PubMed ID: 24795161
[TBL] [Abstract][Full Text] [Related]
16. Channelopathies in children and adults.
Wilde AA
Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S41-5. PubMed ID: 18226035
[TBL] [Abstract][Full Text] [Related]
17. Role of risk stratification and genetics in sudden cardiac death.
Rai V; Agrawal DK
Can J Physiol Pharmacol; 2017 Mar; 95(3):225-238. PubMed ID: 27875062
[TBL] [Abstract][Full Text] [Related]
18. Advising a cardiac disease gene positive yet phenotype negative or borderline abnormal athlete: is sporting disqualification really necessary?
Richard P; Denjoy I; Fressart V; Wilson MG; Carré F; Charron P
Br J Sports Med; 2012 Nov; 46 Suppl 1():i59-68. PubMed ID: 23097481
[TBL] [Abstract][Full Text] [Related]
19. Determining the pathogenicity of genetic variants associated with cardiac channelopathies.
Campuzano O; Allegue C; Fernandez A; Iglesias A; Brugada R
Sci Rep; 2015 Jan; 5():7953. PubMed ID: 25608792
[TBL] [Abstract][Full Text] [Related]
20. [Multidisciplinary cardiogenetic counselling].
Fellmann F; Jeanrenaud X; Sekarski N; Michaud K; Hersch D; Fodstad H; Bhuiyan ZA; Schläpfer J
Rev Med Suisse; 2017 May; 13(564):1094-1099. PubMed ID: 28639772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
